Unknown

Dataset Information

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?


ABSTRACT: The COVID-19 has plunged the world into a pandemic that affected millions. The continually emerging new variants of concern raise the question as to whether the existing vaccines will continue to provide sufficient protection for individuals from SARS-CoV-2 during natural infection. This narrative review aims to briefly outline various immunotherapeutic options and discuss the potential of clustered regularly interspaced short palindromic repeat (CRISPR Cas system technology against COVID-19 treatment as specific cure. As the development of vaccine, convalescent plasma, neutralizing antibodies are based on the understanding of human immune responses against SARS-CoV-2, boosting human body immune responses in case of SARS-CoV-2 infection, immunotherapeutics seem feasible as specific cure ag

SUBMITTER: He X 

PROVIDER: S-EPMC8979261 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature